Literature DB >> 445511

Regression of regionally confined melanoma with intra-arterial cis-dichlorodiammineplatinum(II).

J D Pritchard, G M Mavligit, R S Benjamin, Y Z Patt, D B Calvo, S W Hall, G P Bodey, S Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 445511

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

1.  Isolation perfusion of the lower limb with platinum.

Authors:  M Vaglini; F Belli; M Santinami
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

2.  Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma.

Authors:  F Di Filippo; S Carlini; R Garinei; P Perri; M Anzà; F Ferranti; E Saracca; M Schiratti; F Cavaliere; R Cavaliere
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

3.  The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation.

Authors:  V P Chuang; S Wallace; R S Benjamin; N Jaffe; A Ayala; J Murray; J Zornoza; Y Patt; G Mavligit; C Charnsangavej; C S Soo
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

4.  Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

Authors:  E Reed; S H Yuspa; L A Zwelling; R F Ozols; M C Poirier
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 5.  Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective.

Authors:  Robert S Benjamin
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  High-dose cisplatin in disseminated melanoma: a comparison of two schedules.

Authors:  J E Mortimer; S Schulman; J S MacDonald; K Kopecky; G Goodman
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.